Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations

Details 詳細情報について

• CRID

  1362544420572972160

• DOI

  10.1016/j.jtho.2015.12.107

• ISSN

  15560864

• Web Site

  https://api.elsevier.com/content/article/PII:S1556086416002835?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1556086416002835?httpAccept=text/plain

• Data Source

  • Crossref